Cite

HARVARD Citation

    Steinbügl, M. et al. (2021). Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors. Pediatric blood & cancer. 68 (12), p. n/a. [Online]. 
  
Back to record